Doctors looking into hormone therapy as a way to ward off dementia in women
  • Nov 27, 2025

Doctors looking into hormone therapy as a way to ward off dementia in women

U.S. Medicare cuts prices for 15 prescription drugs. Here's what they are
  • Nov 26, 2025

U.S. Medicare cuts prices for 15 prescription drugs. Here's what they are

Quantum BioPharma seeks $700M in 'stock spoofing' lawsuit
  • Nov 26, 2025

Quantum BioPharma seeks $700M in 'stock spoofing' lawsuit

Premier promises Manitoban battling degenerative disease will get temporary coverage after outcry
  • Nov 26, 2025

Premier promises Manitoban battling degenerative disease will get temporary coverage after outcry

Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds
  •  —
  • Nov 25, 2025

Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds

Family distraught as Manitoba maintains it won't pay for treatment for 30-year-old with degenerative disease
  • Nov 25, 2025

Family distraught as Manitoba maintains it won't pay for treatment for 30-year-old with degenerative disease

People who stop using Mounjaro suffer reversal of health benefits, says study
  • Nov 24, 2025

People who stop using Mounjaro suffer reversal of health benefits, says study

Ozempic Drug Fails to Quell Alzheimer's in Novo Nordisk Trials
  •  —
  • Nov 24, 2025

Ozempic Drug Fails to Quell Alzheimer's in Novo Nordisk Trials

Zymeworks wanted to be Canada's first Big Pharma. Despite two blockbusters-in-the-making, that's no longer the plan
  •  —
  • Nov 24, 2025

Zymeworks wanted to be Canada's first Big Pharma. Despite two blockbusters-in-the-making, that's no longer the plan

Eli Lilly joins the $1 trillion club
  • Nov 24, 2025

Eli Lilly joins the $1 trillion club

Doctors respond to US' 'data-free' decision over menopause hormone therapy: 'It's not true'
  • Nov 24, 2025

Doctors respond to US' 'data-free' decision over menopause hormone therapy: 'It's not true'

Pharmacare advisory committee says bilateral model is broken, calls for national essential-medicines list
  • Nov 23, 2025

Pharmacare advisory committee says bilateral model is broken, calls for national essential-medicines list

Manitoban with degenerative disease urges province to cover life-sustaining drug after free coverage lapses
  • Nov 21, 2025

Manitoban with degenerative disease urges province to cover life-sustaining drug after free coverage lapses

B.C. toddler travels to U.S. for potentially life-changing stem cell treatment
  • Nov 21, 2025

B.C. toddler travels to U.S. for potentially life-changing stem cell treatment

Canada pharmacare report set to be made public
  • Nov 21, 2025

Canada pharmacare report set to be made public

Health Canada approval backlog expected to push back arrival of generic Ozempic
  •  —
  • Nov 21, 2025

Health Canada approval backlog expected to push back arrival of generic Ozempic

Denmark compensates patients for vision loss linked to semaglutide
  • Nov 21, 2025

Denmark compensates patients for vision loss linked to semaglutide

The Trump administration is turning drug review into make-a-deal
  • Nov 21, 2025

The Trump administration is turning drug review into make-a-deal

Your doctor could be receiving payments from a drug company. Why won't anyone tell you?
  • Nov 20, 2025

Your doctor could be receiving payments from a drug company. Why won't anyone tell you?

Millions of Kids Are on ADHD Pills. For Many, It’s the Start of a Drug Cascade.
  • Nov 20, 2025

Millions of Kids Are on ADHD Pills. For Many, It’s the Start of a Drug Cascade.

New Gene-Editing Strategy Could Help Development of Treatments for Rare Diseases
  •  —
  • Nov 20, 2025

New Gene-Editing Strategy Could Help Development of Treatments for Rare Diseases

Infamous antidepressant drug trial back in spotlight after journal sued
  • Nov 19, 2025

Infamous antidepressant drug trial back in spotlight after journal sued

Health Canada approves NILEMDO for the reduction of LDL-cholesterol in Canadians at Risk of CVD
  • Nov 18, 2025

Health Canada approves NILEMDO for the reduction of LDL-cholesterol in Canadians at Risk of CVD

FDA's new warning on Sarepta raises more questions on heart risk
  • Nov 18, 2025

FDA's new warning on Sarepta raises more questions on heart risk

Get Canada’s essential briefing on health policy, science, and system change.  Get Briefing